Clinical Research Directory
Browse clinical research sites, groups, and studies.
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases
Sponsor: Emory University
Summary
This trial studies how well dynamic susceptibility contrast-magnetic resonance imaging (MRI) works in determining radiation necrosis and tumor progression in participants with cancer that has spread to the brain and are being treated with radiation therapy. Diagnostic procedures, such as dynamic susceptibility contrast-MRI, may improve the ability to determine indeterminate post-treatment changes seen on imaging after radiation therapy.
Official title: Diagnostic Accuracy of Dynamic Susceptibility Contrast (DSC) Perfusion MRI to Determine Radiation Necrosis Versus Tumor Progression in Brain Metastases Treated With Stereotactic Radiosurgery
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2018-11-28
Completion Date
2021-06-15
Last Updated
2026-04-24
Healthy Volunteers
No
Interventions
Dynamic Susceptibility Contrast-MRI (DSC-MRI)
Undergo DSC-MRI
Magnetic Resonance Imaging (MRI)
Undergo diagnostic MRI
Locations (2)
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, United States
Emory Saint Joseph's Hospital
Atlanta, Georgia, United States